Cannabis oil and asthma help? How to use RSO oil(cannabis oil)? Sublingually: It’s the fastest form of absorption. You put a drop under the tongue and hold it for a minute or two. It usually takes the average person about 90 days to ingest the full 60 gram or 60 ml RSO oil treatment. I suggest that people start with three doses per day, about the size of half a grain of short-grained dry rice. The patient should take this dosage every 8 hours, early in the morning, then again in the afternoon, and then they should take their final dose of the day, about an hour before bedtime. It should also be noted that as a patient begins to ingest this oil, the patient does not normally feel the RSO oil’s effects until about an hour after they have taken their dosage, so please be aware of this fact. A beginner’s dose such as I am describing would equal about 1/4 of a drop. Find additional info at rso oil.
The best light intensity for plant growth during flowering: Plant growth rate increases up to PAR (PPFD) levels of 1,500 µmols/m2/sec at optimum temperature and atmospheric levels of CO2. We recommend a PAR level of 750 µmols/m2/sec for your grow room. Increasing PAR above this level does not increase the growth rate enough to justify the additional energy consumed. The PAR levels (PPFD) vs Photosynthesis (Growth Rate) for Cannabis Sativa at 30 Degrees Celcius and normal atmospheric CO2 levels.
Rick Simpson is one of the world’s leading Marijuana activists and the founder of Phoenix Tears. He is the person who rediscovered the cure for cancer with the absolute most amazing plant, Marijuana! His journey started in 2003 when he was diagnosed with basal cell carcinoma skin cancer. He had three spots of cancer on his body, two on his face and one on his neck. After being diagnosed with cancer he made a decision, and that decision has changed the world’s view on cannabis entirely. He reopened the worlds eye’s to the amazing benefits of cannabis. Read more details at rsocancerfree.com.
Tommy Chong on battling rectal cancer by using cannabis oil. Currently, 18 states have legalized the recreational use of marijuana and 36 states have legalized the medicinal use of cannabis. Many cancer patients (16-24%) use cannabis oil to curtail symptoms related to cancer or cancer treatment. Dr. Newcomb, the first author of the publication, stated that “cannabis has some important properties that motivate cancer patients to use it for nausea and vomiting, appetite, pain, fatigue.” Previous studies indicate that cannabis is widely used among cancer patients with late-stage disease or with other poor mental or physical health states. Due to improvements in early detection and cancer treatments, the number of cancer survivors will expand by one million per year, which includes at least 150,000 colorectal cancer (CRC) patients. Therefore, about 2.7 to 4 million survivors may intentionally use cannabis for symptom management or other reasons. Presently, cannabis use and its side effects are not monitored among cancer patients and survivors. The Newcomb Group, from the Division of Public Health Sciences, evaluated the demographic, behavioral, and clinical characteristics of cannabis use among colorectal cancer patients from Washington State. CRC has a high prevalence and several treatments with side effects thus, CRC provides a good model for understanding cannabis use among men and women with cancer. This study is published in Cancer Causes & Control.
However, the exploration of the CBD pharmacological mechanism is the truly time consuming process. “Natural products are generally more than ‘dirty’, often there are many targets, but this does not hinder aspirin and metformin into a generation of gods.” Yan Chao said. In order to find the main target of CBD inhibiting glioma, the team traversed all reports or predicted cannabin possible targets, combined with chemical student probes, and finally locks the target in TRPV4 ion channel; next The team’s strict pharmacological experiment design demonstrates that the CBD can act as a TRPV4 agonist, causing calcium ion internal flow, resulting in mitochondrial dysfunction, inducing mitochondrial autophagy, and ultimately killing organoma cells.